Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RenalGuard System for Prevention of Contrast Induced Nephropathy - A Randomized Trial

NCT02029820 is registered in ClinicalTrials.gov with Hospital Sao Lucas da PUCRS as lead sponsor.

NCT NCT02029820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02029820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RenalGuard System for Prevention of Contrast Induced Nephropathy - A Randomized Trial
Lead sponsor
Hospital Sao Lucas da PUCRS
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2012
Completion date
December 31, 2015
Enrollment
210 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

radiographic contrast agent nephropathy